rAAV-FHIT (Sidney Kimmel Cancer Center)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerAAV-FHIT (Sidney Kimmel Cancer Center)
Drug Alias Nameoncolytic adeno-associated virus therapy expressing FHIT (Sidney Kimmel Cancer Center)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulantsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSidney Kimmel Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSidney Kimmel Cancer Center
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A